Latest FDA Stories
Forty-three percent of pharma and life sciences execs now support FDA evaluating drugs based on both clinical and economic effectiveness NEW YORK, Jan.
--Recent FDA Audit is Neuland's Ninth Successful FDA Review; Matched by Record of Positive Regulatory Performance in Europe and Japan-- HYDERABAD, India, Jan.
LEXINGTON, Massachusetts, January 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the United States Food and Drug Administration (FDA) has granted
New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwide PLEASANTON, Calif., Jan.
TARRYTOWN, N.Y. and PARIS, Jan. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
The U.S. Supreme Court has denied a petition submitted by Teva Pharmaceuticals USA Inc. in which the generic drug maker sought to challenge a lawsuit brought over generic drug injuries.
CDRH broke its own device warning letter record in 2013 and experts predict that trend will continue in 2015.
DUBLIN, Jan. 23, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) notes the announcement today by NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) that the U.S.
With today's approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have been distributed worldwide BASEL, Switzerland, Jan.
ORLANDO, Fla. and DUBLIN, Jan. 23, 2015 /PRNewswire/ -- Immune Therapeutics, Inc. today announced the signing of the agreement with KRS Global Biotechnology, Inc.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.